ZYME
ZYME
NASDAQ · Biotechnology

Zymeworks Inc

$29.63
+0.90 (+3.11%)
As of Nov 7, 9:57 PM ET ·
Financial Highlights (FY 2026)
Revenue
98.55M
Net Income
-75,448,334
Gross Margin
—
Profit Margin
-76.6%
Rev Growth
-36.4%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 42.5% 42.5%
Operating Margin -87.3% -78.6% 19.5% 17.9%
Profit Margin -76.6% -72.7% 15.6% 18.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 98.55M 155.02M 182.20M 158.08M
Gross Profit — — 77.45M 67.20M
Operating Income -86,071,620 -121,856,941 35.58M 28.36M
Net Income -75,448,334 -106,816,895 28.41M 28.63M
Gross Margin — — 42.5% 42.5%
Operating Margin -87.3% -78.6% 19.5% 17.9%
Profit Margin -76.6% -72.7% 15.6% 18.1%
Rev Growth -36.4% -36.4% +8.1% +23.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 595.07M 530.52M
Total Equity — — 1.01B 987.85M
D/E Ratio — — 0.59 0.54
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -82,657,264 -123,524,305 52.86M 47.86M
Free Cash Flow — — 21.80M 16.91M